Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced ...
ERAPs (ERAP1 and ERAP2) are emerging therapeutic targets associated with multiple autoimmune diseases.Genomics will assemble the largest available genetic resource to evaluate how ERAP variants ...
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...
21h
Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update
KT-621 (STAT6) parallel Phase 2b trials, BROADEN2 in atopic dermatitis and BREADTH in asthma, ongoing with data expected by mid-2027 and late ...
SC allowed classification of Odomos under HSN 38089191 to stand, holding that market identity and consumer understanding ...
Shattuck Labs, Inc. (NASDAQ:STTK) is one of the best performing small cap stocks so far in 2026. Cantor Fitzgerald initiated ...
Bambusa's lead product candidate, BBT001 is a next-generation long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-31 for the treatment of atopic ...
Huahui Health today announced that it has entered into a global exclusive option, license and collaboration agreement with BeOne Medicines for HH160, a novel trispecific antibody in oncology ...
FOOD MANUFACTURERS are urging the National Nutrition Council (NNC) to revisit proposed nutrient thresholds laid down in the ...
An examination of litigation trends involving the Illinois Genetic Information Privacy Act (GIPA), which regulates the ...
Endometriosis, a chronic inflammatory disease that affects approximately one in ten women of reproductive age—around 190 ...
Dax Zey was born on January 1, 2026. It was Herasight’s 11th baby, and Chase and Arthur’s first. He was as healthy as his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results